<?xml version="1.0" encoding="UTF-8"?>
<ref id="R55">
 <label>55.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sharman</surname>
    <given-names>JP</given-names>
   </name>
   <name>
    <surname>Coutre</surname>
    <given-names>SE</given-names>
   </name>
   <name>
    <surname>Furman</surname>
    <given-names>RR</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Final results of a randomized, phase III Study of rituximab with or without idelalisib followed by open-label idelalisib in patients with relapsed chronic lymphocytic leukemia</article-title>. 
  <source>
   <italic toggle="yes">J Clin Oncol.</italic>
  </source>
  <year>2019</year>;
  <volume>37</volume>:
  <fpage>1391</fpage>â€“
  <lpage>1402</lpage>.
  <pub-id pub-id-type="pmid">30995176</pub-id>
 </mixed-citation>
</ref>
